These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 18837790)

  • 21. Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease.
    Tian Y; Seumois G; De-Oliveira-Pinto LM; Mateus J; Herrera-de la Mata S; Kim C; Hinz D; Goonawardhana NDS; de Silva AD; Premawansa S; Premawansa G; Wijewickrama A; Balmaseda A; Grifoni A; Vijayanand P; Harris E; Peters B; Sette A; Weiskopf D
    Cell Rep; 2019 Dec; 29(13):4482-4495.e4. PubMed ID: 31875555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice.
    Hunsawong T; Sunintaboon P; Warit S; Thaisomboonsuk B; Jarman RG; Yoon IK; Ubol S; Fernandez S
    Vaccine; 2015 Mar; 33(14):1702-10. PubMed ID: 25701315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell responses and dengue haemorrhagic fever.
    Screaton G; Mongkolsapaya J
    Novartis Found Symp; 2006; 277():164-71; discussion 171-6, 251-3. PubMed ID: 17319161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006.
    Fried JR; Gibbons RV; Kalayanarooj S; Thomas SJ; Srikiatkhachorn A; Yoon IK; Jarman RG; Green S; Rothman AL; Cummings DA
    PLoS Negl Trop Dis; 2010 Mar; 4(3):e617. PubMed ID: 20209155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of type I interferon responses in dengue and severe dengue in children in Paraguay.
    Talarico LB; Byrne AB; Amarilla S; Lovera D; Vázquez C; Chamorro G; Acosta PL; Ferretti A; Caballero MT; Arbo A; Polack FP
    J Clin Virol; 2017 Dec; 97():10-17. PubMed ID: 29078078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A protective role for dengue virus-specific CD8+ T cells.
    Yauch LE; Zellweger RM; Kotturi MF; Qutubuddin A; Sidney J; Peters B; Prestwood TR; Sette A; Shresta S
    J Immunol; 2009 Apr; 182(8):4865-73. PubMed ID: 19342665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
    Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
    J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?
    Loke H; Bethell DB; Phuong CX; Dung M; Schneider J; White NJ; Day NP; Farrar J; Hill AV
    J Infect Dis; 2001 Dec; 184(11):1369-73. PubMed ID: 11709777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model.
    Kyle JL; Balsitis SJ; Zhang L; Beatty PR; Harris E
    Virology; 2008 Oct; 380(2):296-303. PubMed ID: 18774583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of dengue virus infection and disease.
    Yauch LE; Shresta S
    Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.
    Rothman AL
    Nat Rev Immunol; 2011 Jul; 11(8):532-43. PubMed ID: 21760609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma leakage in dengue haemorrhagic fever.
    Srikiatkhachorn A
    Thromb Haemost; 2009 Dec; 102(6):1042-9. PubMed ID: 19967133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sculpting humoral immunity through dengue vaccination to enhance protective immunity.
    Crill WD; Hughes HR; Trainor NB; Davis BS; Whitney MT; Chang GJ
    Front Immunol; 2012; 3():334. PubMed ID: 23162552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive immune responses to primary and secondary dengue virus infections.
    St John AL; Rathore APS
    Nat Rev Immunol; 2019 Apr; 19(4):218-230. PubMed ID: 30679808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection.
    Her Z; Kam YW; Gan VC; Lee B; Thein TL; Tan JJ; ; Lee LK; Fink K; Lye DC; Rénia L; Leo YS; Ng LF
    J Infect Dis; 2017 Jan; 215(1):42-51. PubMed ID: 28077582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dengue virus vaccine development.
    Yauch LE; Shresta S
    Adv Virus Res; 2014; 88():315-72. PubMed ID: 24373316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus-specific T lymphocytes home to the skin during natural dengue infection.
    Rivino L; Kumaran EA; Thein TL; Too CT; Gan VC; Hanson BJ; Wilder-Smith A; Bertoletti A; Gascoigne NR; Lye DC; Leo YS; Akbar AN; Kemeny DM; MacAry PA
    Sci Transl Med; 2015 Mar; 7(278):278ra35. PubMed ID: 25761891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.